We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Adults aged 75 and over, residents in a care home for older adults and immunosuppressed individuals will be eligible for a spring booster.
JCVI advises vaccine top-up for over-75s, immunosuppressed and residents in care homes for older adults.
This adapted COVID-19 vaccine targets both the original coronavirus (SARS-CoV-2) and the Omicron BA.4 and BA.5 sub-variants.
Nearly 17.5 million eligible people received their COVID-19 autumn booster jab, with tens of thousands coming forward in the final week of the programme.
The UK Commission on Covid Commemoration is now considering all responses and final recommendations will be put to Government in Spring.
JCVI makes interim recommendations to government on the COVID-19 vaccination programme for 2023.
The UK Commission on Covid Commemoration held its sixth meeting.
From today, the Rosalind Franklin Laboratory will cease to process PCR tests for COVID-19 in response to reduced demand.
Offer of free personal protective equipment (PPE) for frontline health and care staff extended until 31 March 2024.
From this week, UKHSA launches a new COVID-19 surveillance programme, sequencing positive COVID-19 tests from a sample of passengers flying in from China to Heathrow.
The Secretary of State for Health and Social Care, Steve Barclay, updated Parliament on what the government is doing to help the NHS deal with immediate winter pressures.
Measures introduced to improve the UK’s ability to detect potential new variants of COVID-19 from China.
As pupils and students return to school following the Christmas break, UKHSA is reminding people that winter illnesses continue to circulate at high levels.
England joins a growing list of countries across the world to announce temporary measures as COVID cases rise in China ahead of borders re-opening next week.
Moderna to invest in mRNA research and development (R&D) in the UK, and build a state-of-the-art vaccine manufacturing centre with the ability to produce up to 250 million vaccines a year.
This new vaccine, VidPrevtyn Beta, has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
The UK Commission on Covid Commemoration held its fifth meeting.
The Comirnaty COVID vaccine has met the MHRA’s required safety, quality and effectiveness standards to be authorised for use in this age group
The UK Health Security Agency (UKHSA) has published findings of an investigation following errors at the private Immensa laboratory in Wolverhampton.
The UK Commission on Covid Commemoration held its fourth meeting.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.